"During 2023-29, 15 blockbuster drugs (including biological products) are going to be off-patented worth USD 112 billion which would provide a tremendous growth opportunity for India pharmaceutical companies by another USD 10 billion," the official said.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/wyNe6xs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment